Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    An NIH-wide notice explains the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    1.0%
    Check dated 2026-10-21T12:15:17.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T13:51:28.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.7.0' is added to the study record history, updating the version history. The previous revision 'Revision: v3.6.6' is removed from the current view.
    Difference
    0.1%
    Check dated 2026-09-16T21:53:30.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-02T18:09:38.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The record history now lists a new revision (v3.6.5) that supersedes the previous version (v3.6.4).
    Difference
    0.1%
    Check dated 2026-08-12T09:00:02.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The record history now shows a new entry for Revision: v3.6.4, updating the page's revision metadata from v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-28T05:27:29.000Z thumbnail image

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.